SARAH YOUNG: Open Payments
NPI 1942708383 · NEWPORT BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$639 in 15 payments from 6 companies in 2025. Trend: 2023 $105 · 2024 $636 · 2025 $639
Food & beverage: $639
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $235 |
| Eisai Inc. | 3 | $173 |
| Amgen Inc. | 1 | $121 |
| Biogen, Inc. | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Merz Pharmaceuticals, LLC | 1 | $29 |
Products named: Leqembi, KISUNLA, Repatha, AMYVID, LEQVIO, INBRIJA.
Industry payments across CA — which companies pay providers there.
